Crossmark

Preclinical Toxicity Study and Tissue Distribution of YSCH- 01 Injection via Intratumoral Injection, Intravenous Injection, and Intraperitoneal Injection in Syrian Hamsters

Crossref DOI link: https://doi.org/10.1007/s11095-025-03863-x

Published Online: 2025-05-08

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Ruoyu

Fang, Xian-Long

Raza, Hafiz Khuram
Funding

Funding for this research was provided by:

Academician Expert Workstation Grants (20R9004076411)

Shanghai science and technology support project on biomedicine in the action plan of Science and Technology Innovation (19431904200)
License Information

Text and Data Mining valid from 2025-05-08

Version of Record valid from 2025-05-08
More Information

Article History

Received: 3 January 2025

Accepted: 13 April 2025

First Online: 8 May 2025

Declarations

:

: This study was approved by Institutional Animal Care and Use Committee of InnoStar on 1 st January 2022.

: Xian-long Fang holds an ownership interest (including patents of YSCH‑01) in Yuansong Biotechnology Limited Company.

Document is current

Any future updates will be listed below